Patent · US Active

Capsid assembly modulator dosing regimen

US10973801B2 · kind B2 · utility

0Cited by

89References

18Claims

0Family size

Assignee

Janssen Sciences Ireland Unlimited Company · IE

Inventors

Koen Vandyck · Beringen, BE
Oliver Lenz · Sint-Katelijne-Waver, BE
Claire Elisabeth Balmain · Ekeren, BE
Jan SNOEYS · Westmalle, BE
Joris Jozef VANDENBOSSCHE · Beerse, BE
Dominique Josiane W. VERSTRAETE · Lokeren, BE
Jeysen Zivan YOGARATNAM · Danville, US
Maria JANSENS · Turnhout, BE
Frederic VAN DYCKE · Nijlen, BE

Key dates

Filing date	Mar 13, 2019
Grant date	Apr 13, 2021
Priority date	—
Expiry date	Mar 13, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to methods of using a capsid assembly inhibitor for the treatment of hepatitis B virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.